Mark de Rosch

Mark De Rosch, PhD, FRAPS has a comprehensive work experience in the pharmaceutical industry. Mark has held various senior roles in regulatory affairs, quality assurance, and drug development at companies like Samsara Therapeutics, Aura Biosciences, and Epizyme, Inc. Their career progression includes positions such as Chief Operating Officer, Chief Regulatory Officer, and Senior Vice President. Mark has also worked as a Drug Development Advisor and Regulatory Consultant, showcasing their expertise and knowledge in the field.

Mark De Rosch, PhD, FRAPS, obtained their B.S. in Chemistry/Biochemistry from the University of Wisconsin-Parkside in 1985. Mark went on to earn their Ph.D. in Inorganic Chemistry from UC San Diego in 1990. In 2000, they also became a RAPS Member through the Regulatory Affairs Certification Program.